Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues:    
Product Revenue $ 643,187 $ 737,643
Product Revenue - Related party 24,063 380
Total Revenues 667,250 738,023
Cost of Sales:    
Product Cost of Sales (258,721) (200,028)
Gross Income 408,529 537,995
Administrative Expenses 790,529 923,560
Sales and Marketing Expenses 556,655 725,324
Sales and Marketing Expenses - Related Party 32,279
Research and Development Expenses 348,442 363,292
Amortization of Non-Current Assets 42,777 42,777
Loss from Operations (1,362,153) (1,516,958)
Other (Income)/Expenses    
Foreign Currency Transaction (Gain)/Loss (10,346) 2,256
Interest and Dividend Income (2,537) (10,285)
Other Income
Total Other Income (12,883) (8,029)
Loss Before Income Taxes (1,349,270) (1,508,929)
Income Tax Benefit
Net Loss Attributable to Common Stockholders (1,349,270) (1,508,929)
Other Comprehensive Income    
Net Unrealized Gains on Marketable Securities 156 8,534
Total Other Comprehensive Income 156 8,534
Comprehensive Loss $ (1,349,114) $ (1,500,395)
Basic and diluted loss per common share $ (0.19) $ (0.28)
Weighted average basic and diluted common shares outstanding 6,993,574 5,425,045